Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Efficacy of Modified Guilu Erxian Glue in Treating Patients With Myasthenia Gravis: A Retrospective Cohort Study

NCT07472777 is registered in ClinicalTrials.gov with Beijing University of Chinese Medicine as lead sponsor.

NCT NCT07472777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07472777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Efficacy of Modified Guilu Erxian Glue in Treating Patients With Myasthenia Gravis: A Retrospective Cohort Study
Lead sponsor
Beijing University of Chinese Medicine
Phase
Observational
Overall status
Completed
Start date
January 1, 2024
Completion date
July 31, 2024
Enrollment
231 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myasthenia gravis (mg)